Acadia Healthcare (ACHC): UK Entry Is A LT Growth Driver - Jefferies

Jefferies analyst, Brian Tanquilut, reiterated his Buy rating on shares of Acadia Healthcare (NASDAQ: ACHC) and believes that the UK business, which dragged the stock down in 2016, will be a longer-term growth driver that could help the company double revenues and deliver 20% annual EPS growth.

The analyst also sees ACHC's depressed valuation at 14x P/E (0.7x PE/G vs. group avg. of 1.1x) improving compared to comps as UK market growth accelerates (6% vs. US at 3%).

No change to the price target of $55.

For an analyst ratings summary and ratings history on Acadia Healthcare click here. For more ratings news on Acadia Healthcare click here.

Shares of Acadia Healthcare closed at $34.87 yesterday.

You May Also Be Interested In

• Jefferies Downgrades Enphase Energy (ENPH) to Hold, 'Still Muddling Through'
• Boston Scientific (BSX) PT Raised to $80 at BTIG
• Bunge (BG) PT Raised to $122 at Citi